Key result
Higher pre-operative HDL-C levels were not associated with a reduced risk of major cardiovascular events or death in patients with coronary artery disease undergoing elective CABG.
Why the study?
Are high pre-operative HDL-C levels associated with reduced cardiovascular events in patients with coronary artery disease undergoing elective CABG?
Cohort (n=1,548)
No
Are high pre-operative HDL-C levels associated with reduced cardiovascular events in patients with coronary artery disease undergoing elective CABG?
Higher pre-operative HDL-C levels do not protect against, and may even be associated with increased, major adverse cardiovascular events in CAD patients undergoing CABG.
Answers are grounded in this paper and cite their sources.
High pre-operative HDL-C should not guide risk assessment in elective CABG; leaves open any causal role in post-operative outcomes.
AIMS: Primary prevention studies have confirmed that high-density lipoprotein cholesterol (HDL-C) levels are strongly associated with reduced cardiovascular events. However, recent evidence suggests that HDL-C functionality may be impaired under certain conditions. In the present study, we hypothesize that HDL-C may lose their protective role in the secondary prevention of coronary artery disease (CAD). METHODS AND RESULTS: A consecutive series of 1548 patients undergoing isolated first-time elective CABG at one institution between 2004 and 2009 was studied. According to the ATPIII criteria, pre-operative HDL-C values were used to identify patients with high (Group A) vs. low HDL-C (Group B). To eliminate biased estimates, a propensity score model was built and two cohorts of 1:1 optimally matched patients were obtained. Cumulative survival and major adverse cardiovascular events (MACE) were analysed by means of Kaplan-Meier method. Cox proportional-hazards regression models were used to identify independent predictors of MACE and death. Propensity matching identified two cohorts of 502 patients each. At a median follow-up time of 32 months, there were 44 out of 502 (8.8%) deaths in Group A and 36 out of 502 deaths in Group B (7.2%, HR 1.19; P = 0.42). MACE occurred in 165 out of 502 (32.9%) in Group A and 120 out of 502 (23.9%) in Group B (P = 0.04). Regression analysis showed that pre-operative HDL-C levels were not associated with reduced but rather increased MACE occurrence during follow-up (HR 1.43, P = 0.11). CONCLUSION: Higher HDL-C levels are not associated with reduced risk of vascular events in CAD patients undergoing CABG. Our findings may support efforts to improve HDL-C functionality instead of increasing their levels.
No takes yet. Share an insight, caveat, or question.
Angeloni et al. (2013) conducted a cohort in Coronary artery disease (n=1,548). High HDL-C vs. Low HDL-C was evaluated on Major adverse cardiovascular events (MACE) (HR 1.43, p=0.11). Higher pre-operative HDL-C levels were not associated with a reduced risk of major cardiovascular events or death in patients with coronary artery disease undergoing elective CABG.
Synapse has enriched 10 related papers. Consider them for comparative context: